These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3331496)

  • 1. [The clinical significance of antibodies to vimentin intermediate filaments in patients with rheumatoid arthritis].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1987 Oct; 27(5):356-63. PubMed ID: 3331496
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.
    Kurki P; Helve T; Virtanen I
    J Rheumatol; 1983 Aug; 10(4):558-62. PubMed ID: 6352937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to vimentin intermediate filaments in sera from patients with SLE and RA: quantitation by solid phase radioimmunoassay.
    Alcover A; Ramirez-Lafita F; Hernandez C; Nieto A; Avila J
    J Rheumatol; 1985 Apr; 12(2):233-6. PubMed ID: 3897530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of the antinuclear factor determined by the immunofluorescent method in rheumatoid arthritis].
    Król W; Kolarzowska B
    Pol Tyg Lek; 1969 Mar; 24(11):399-400. PubMed ID: 4892175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of anti-vimentin antibody assay].
    Nakamura Y; Takahashi T; Niwa A
    Nihon Rinsho; 1990 Feb; 48 Suppl():509-12. PubMed ID: 2192144
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
    Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
    Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection.
    Boehme MW; Kataaha PK; Holborow EJ
    Clin Exp Immunol; 1989 Aug; 77(2):230-3. PubMed ID: 2476270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear factors and rheumatoid arthritis].
    Jarlov NV
    Ugeskr Laeger; 1968 Sep; 130(38):1571-2. PubMed ID: 4882476
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-vimentin antibodies in blood and synovial fluids of patients with rheumatoid polyarthritis].
    Boehme M; Jouquan J; Blaschek M; Seigneurin JM; Le Goff P; Youinou P
    Rev Rhum Mal Osteoartic; 1987 Dec; 54(12):817-22. PubMed ID: 3432984
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
    Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
    Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the proteins associated with Sa antigen].
    Chen H; Yao ZJ; Tang FL
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1896-900. PubMed ID: 17064527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
    Ordeig J; Guardia J
    J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].
    Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C
    Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research on the percent of positivity of the antiperinuclear factor in rheumatoid arthritis: correlation with some clinical and sere-immunological aspects].
    Damasio E; Rossi F; Viara M
    Reumatismo; 1967; 19(4):243-56. PubMed ID: 4876210
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
    Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
    J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P
    Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.